Coya Therapeutics (NASDAQ:COYA) Earns Buy Rating from D. Boral Capital
Coya Therapeutics (NASDAQ:COYA – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at D. Boral Capital in a report released on Monday,Benzinga reports. They presently have a $15.00 target price on the stock. D. Boral Capital’s price objective would suggest a potential upside of 123.88% from the stock’s current price. […]
Coya Therapeutics (NASDAQ:COYA – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at D. Boral Capital in a report released on Monday,Benzinga reports. They presently have a $15.00 target price on the stock. D. Boral Capital’s price objective would suggest a potential upside of 123.88% from the stock’s current price. […]
